Med Ed 101
FEBRUARY 27, 2022
I’ve precepted many pharmacy students who are preparing to enter the match for a pharmacy residency position. Next to preparing for various pharmacy board exams, trying to get a pharmacy residency can be one of the most anxiety-stoking events in a young pharmacist’s career. Tony Guerra is a good friend of mine and cares deeply […].
pharmaphorum
FEBRUARY 27, 2022
Orphazyme’s hopes of getting EU approval for its Niemann-Pick disease type C (NPC) therapy arimoclomol after a rejection by the US FDA last year are dwindling fast. The EMA’s human medicines committee has told Orphazyme it is unlikely to recommend approval of arimoclomol for the ultra rare genetic condition at its next meeting in March, prompting the Danish biotech to assess its “strategic options.” Copenhagen-based Orphazyme was summoned to deliver an oral presentation i
Expert insights. Personalized for you.
40 
Let's personalize your content